You are viewing an incomplete version of our website. Please click to reload the website as full version.

BCL2-Like 11 (Apoptosis Facilitator) (BCL2L11) (Intermediate Domain 2) Peptide

Details for Product No. ABIN1382221, Supplier: Log in to see
Protein Name
  • bim
  • BAM
  • BIM
  • BOD
  • 1500006F24Rik
  • Bim
  • Bod
  • BimL
  • BIMEL
  • BCL2-like 11
  • BCL2-like 11 (apoptosis facilitator)
  • bcl2l11
  • LOC100345483
  • BCL2L11
  • Bcl2l11
Protein Region
Intermediate Domain 2
Origin
Human
5
3
3
3
2
2
2
1
Application
Blocking Peptide (BP)
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Blocked Antibody anti-BIM antibody (BCL2-Like 11 (Apoptosis Facilitator)) (Middle Region 2) (ABIN1031197)
Characteristics 16 amino acids near the middle of human Bim.
Human
Research Area Cancer, Apoptosis/Necrosis, Innate Immunity, Alzheimer's Disease
Application Notes Bim peptide is used for blocking the activity of Bim.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Zhou, Liu, Payne, Lutz, Chittenden: "Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155." in: The Journal of biological chemistry, Vol. 275, Issue 32, pp. 25046-51, 2000 (PubMed).

OConnor, Strasser, OReilly, Hausmann, Adams, Cory, Huang: "Bim: a novel member of the Bcl-2 family that promotes apoptosis." in: The EMBO journal, Vol. 17, Issue 2, pp. 384-95, 1998 (PubMed).

Ottilie, Diaz, Horne, Chang, Wang, Wilson, Chang, Weeks, Fritz, Oltersdorf: "Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins." in: The Journal of biological chemistry, Vol. 272, Issue 49, pp. 30866-72, 1998 (PubMed).